Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric P Leip

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|February 13, 2004
Plasma natriuretic peptide levels and the risk of cardiovascular events and deathThomas J Wang, Martin G Larson, Daniel Levy, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2003
Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart StudyMichael H Freitag, Martin G Larson, Daniel Levy, et al.
Journal of the American Society of Nephrology : JASN|September 2, 2004
Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart StudyCaroline S Fox, Qiong Yang, L Adrienne Cupples, et al.
Circulation|February 8, 2006
Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of ageDonald M Lloyd-Jones, Eric P Leip, Martin G Larson, et al.
The American Journal of Cardiology|July 20, 2002
Impact of age and sex on plasma natriuretic peptide levels in healthy adultsThomas J Wang, Martin G Larson, Daniel Levy, et al.
Sleep|October 31, 2006
Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sampleAnjali A Patwardhan, Martin G Larson, Daniel Levy, et al.
Journal of the American Society of Nephrology : JASN|December 31, 2005
Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart studyCaroline S Fox, Martin G Larson, Ramachandran S Vasan, et al.
Future Oncology (London, England)|September 14, 2019
Glasdegib plus intensive/nonintensive chemotherapy in untreated acute myeloid leukemia: BRIGHT AML 1019 Phase III trialsJorge E Cortes, Hervé Dombret, Akil Merchant, et al.
Circulation|December 11, 2002
Lifetime risk for developing congestive heart failure: the Framingham Heart StudyDonald M Lloyd-Jones, Martin G Larson, Eric P Leip, et al.
Circulation|May 29, 2003
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart StudyThomas J Wang, Martin G Larson, Daniel Levy, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|February 13, 2004
Plasma natriuretic peptide levels and the risk of cardiovascular events and deathThomas J Wang, Martin G Larson, Daniel Levy, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2003
Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart StudyMichael H Freitag, Martin G Larson, Daniel Levy, et al.
Journal of the American Society of Nephrology : JASN|September 2, 2004
Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart StudyCaroline S Fox, Qiong Yang, L Adrienne Cupples, et al.
Circulation|February 8, 2006
Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of ageDonald M Lloyd-Jones, Eric P Leip, Martin G Larson, et al.
The American Journal of Cardiology|July 20, 2002
Impact of age and sex on plasma natriuretic peptide levels in healthy adultsThomas J Wang, Martin G Larson, Daniel Levy, et al.
Sleep|October 31, 2006
Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sampleAnjali A Patwardhan, Martin G Larson, Daniel Levy, et al.
Journal of the American Society of Nephrology : JASN|December 31, 2005
Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart studyCaroline S Fox, Martin G Larson, Ramachandran S Vasan, et al.
Future Oncology (London, England)|September 14, 2019
Glasdegib plus intensive/nonintensive chemotherapy in untreated acute myeloid leukemia: BRIGHT AML 1019 Phase III trialsJorge E Cortes, Hervé Dombret, Akil Merchant, et al.
Circulation|December 11, 2002
Lifetime risk for developing congestive heart failure: the Framingham Heart StudyDonald M Lloyd-Jones, Martin G Larson, Eric P Leip, et al.
Circulation|May 29, 2003
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart StudyThomas J Wang, Martin G Larson, Daniel Levy, et al.
Pageof 3